Health and Human Services Secretary Robert F. Kennedy Jr. announced Monday that the federal health department will implement measures aimed at reducing antidepressant prescribing in the United States. The announcement came during an event hosted by the Make America Healthy Again Institute focused on mental health policy.

Kennedy outlined what he termed a "deprescribing" initiative targeting psychiatric medications, particularly selective serotonin reuptake inhibitors (SSRIs). The health secretary has previously expressed concerns about what he views as overuse of psychiatric medications among Americans.

The new policies represent part of Kennedy's broader health agenda since taking office in the Trump administration. Kennedy has been a vocal critic of current psychiatric medication practices, though he has not provided scientific evidence to support some of his claims about these drugs.

Mental health professionals have raised concerns about the initiative, with some psychiatrists arguing that the nation's mental health crisis stems from inadequate access to care rather than overmedication. The specific implementation details and timeline for the federal measures have not yet been fully outlined.

Kennedy, who follows a carnivore diet, has made reforming America's approach to health and medication a central focus of his role as health secretary. The announcement signals a significant shift in federal health policy regarding psychiatric care and medication management.